In this episode of The World of the API  podcast, we have a chat with Teva Environmental, Social, Governance (ESG) experts, Itamar Schwartz and Adam Ajzensztejn about ESG in pharma. We talk about why ESG is such a buzz word at the moment, what impact the pharma industry can actually have, and what makes Teva's recent $5 billion sustainability-linked bond the first of its kind.